Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, Department of Polymer Science and Engineering, College of Chemistry, Chemical Engineering and Materials Science, Soochow University , Suzhou 215123, China.
Department of Anesthesiology and Critical Care Medicine, Zhongshan Hospital, Fudan University , Shanghai 200032, China.
ACS Appl Mater Interfaces. 2017 Mar 29;9(12):10504-10511. doi: 10.1021/acsami.7b00387. Epub 2017 Mar 15.
Pyrrolidinium-type small molecule ionic liquids (ILs), poly(ionic liquid) (PIL) homopolymers, and their corresponding PIL membranes were synthesized and used for antibacterial applications. The influences of substitutions at the N position of pyrrolidinium cation on the antimicrobial activities against both Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) were studied by minimum inhibitory concentration (MIC). The antibacterial efficiency of both the small molecule ILs and PIL homopolymers increased with the increase of the alkyl chain length of substitutions. Furthermore, PIL homopolymers show relatively lower MIC values, indicating better antimicrobial activities than those of the corresponding small molecule ILs. However, the antibacterial properties of the PIL membranes are contrary to corresponding ILs and PIL homopolymers, which reduce with the increase of alkyl chain length. Furthermore, the resultant PIL membranes show excellent hemocompatibility and low cytotoxicity toward human cells, demonstrating clinical feasibility in topical applications.
吡咯烷鎓型小分子离子液体 (ILs)、聚离子液体 (PIL) 均聚物及其相应的 PIL 膜被合成并用于抗菌应用。通过最小抑菌浓度 (MIC) 研究了吡咯烷阳离子 N 位取代对金黄色葡萄球菌 (S. aureus) 和大肠杆菌 (E. coli) 的抗菌活性的影响。小分子 ILs 和 PIL 均聚物的抗菌效率随着取代的烷基链长度的增加而增加。此外,PIL 均聚物表现出相对较低的 MIC 值,表明其抗菌活性优于相应的小分子 ILs。然而,PIL 膜的抗菌性能与相应的 ILs 和 PIL 均聚物相反,随着烷基链长度的增加而降低。此外,所得 PIL 膜表现出优异的血液相容性和对人细胞的低细胞毒性,表明其在局部应用中具有临床可行性。
ACS Appl Mater Interfaces. 2017-3-15
ACS Appl Mater Interfaces. 2017-4-18
ACS Biomater Sci Eng. 2017-6-12
ACS Macro Lett. 2015-10-20
J Biomater Appl. 2024-10
ACS Appl Mater Interfaces. 2023-7-19
Bioact Mater. 2024-11-26
Biomedicines. 2023-11-20
Front Cell Infect Microbiol. 2023
Front Bioeng Biotechnol. 2023-1-19